The decision to register the therapy was supported by data from the Phase III TRAILBLAZER-ALZ 2 and TRAILBLAZER-ALZ 6 trials.

The Tobias and Lechleiter families donated $20 million to establish the Institute for Clinical Innovation at IU Health, the largest gift in its history.

Answering questions about Purdue basketball expectations, the lack of hype around the football team, and the best spot for a ...

Purdue coach Matt Painter spoke recently about why the program targeted Oscar Cluff and Liam Murphy out of the transfer ...

Purdue University is launching new academic programs, expanding research capabilities and forging partnerships with one ...

The Tobias-Lechleiter Institute for Clinical Innovation will serve as a hub for "groundbreaking" disease detection and ...

In the past year, giving at Indiana’s Lilly Endowment Inc., long led by chairman and CEO N. Clay Robbins, has gone into ...

Before being named Purdue's women's tennis coach, Raquel Atawo had a decorated pro career and quickly escalated up the ...

After buying thousands of acres northwest of Indianapolis for a contentious technology park, the Indiana Economic Development ...

Novo Nordisk announced it will work with the biotech Septerna to develop oral GLP-1 obesity drugs in a deal worth up to $2.2 ...